Aurinia Pharmaceuticals to Present at Upcoming Investor Conferences
June 04 2019 - 4:05PM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (the
“Company”) today announced that Mr. Peter Greenleaf, Chief
Executive Officer, will present a corporate overview at the
following upcoming investor conferences:
- Jefferies Healthcare Conference on
Friday, June 7, 2019 at 9:30am PT (12:30pm ET) in New York, NY;
and
- Raymond James 2019 Life Sciences and
MedTech Conference on Tuesday, June 18, 2019 at 5:35am (8:35am ET)
in New York, NY.
All presentations will be webcast live and can be accessed via
the investor section of the Aurinia website, www.auriniapharma.com.
A replay of each presentation will also be archived on the Company
website following the event.
About Aurinia
Aurinia Pharmaceuticals Inc. is a late clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations impacted by serious
diseases with a high unmet medical need. The company is currently
developing voclosporin, an investigational drug, for the potential
treatment of lupus nephritis (LN), focal segmental
glomerulosclerosis (FSGS), and dry eye syndrome (DES). The company
is headquartered in Victoria, British Columbia and focuses its
development efforts globally. For further information, see our
website at www.auriniapharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190604005957/en/
Company Contact:Glenn Schulman, PharmD, MPHCorporate
Communicationsgschulman@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2023 to Apr 2024